European Companies Search Engine

EU funding (€6,155,125): A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. Hor 1 Dec 2017 EU Research and Innovation programme "Horizon"

Overview

Text

This publication is not available.

The filing refers to a past date, and does not necessarily reflect the current state.